- Brain Tumors
- Support Services
- Take Action
- About Us
Patients and caregivers are our priority. We focus on groundbreaking research initiatives with the potential to translate promising science from the lab into treatments that improve survival and quality of life.
that the GBM AGILE clinical trial has expanded to recently to evaluate three drugs
hosted by NBTS to convene experts in the field this past year for a Research Roundtable
of our new flagship research initiative, the DDR Consortium, in 2022
Join our diverse community and discuss the critical issues and opportunities facing all stakeholders engaged in treatment development, research, and oversight of research and products for patients with a brain tumor.
See All News